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Abstract
Background:	Authors	were	assigned	the	task	to	develop	case	definitions	for	periodon‐
titis	in	the	context	of	the	2017	World	Workshop	on	the	Classification	of	Periodontal	
and	Peri‐Implant	Diseases	and	Conditions.	The	aim	of	this	manuscript	is	to	review	evi‐
dence	and	rationale	for	a	revision	of	the	current	classification,	to	provide	a	framework	
for	case	definition	that	fully	implicates	state‐of‐the‐art	knowledge	and	can	be	adapted	
as	new	evidence	emerges,	and	to	suggest	a	case	definition	system	that	can	be	imple‐
mented	in	clinical	practice,	research	and	epidemiologic	surveillance.
Methods:	Evidence	gathered	in	four	commissioned	reviews	was	analyzed	and	inter‐
preted	with	special	emphasis	to	changes	with	regards	to	the	understanding	available	
prior	to	the	1999	classification.	Authors	analyzed	case	definition	systems	employed	
for	a	variety	of	chronic	diseases	and	identified	key	criteria	for	a	classification/case	
definition	of	periodontitis.
Results:	The	manuscript	discusses	the	merits	of	a	periodontitis	case	definition	sys‐
tem	based	on	Staging	and	Grading	and	proposes	a	case	definition	framework.	Stage	
I	to	IV	of	periodontitis	is	defined	based	on	severity	(primarily	periodontal	breakdown	
with	reference	to	root	length	and	periodontitis‐associated	tooth	loss),	complexity	of	
management	(pocket	depth,	infrabony	defects,	furcation	involvement,	tooth	hyper‐
mobility,	masticatory	dysfunction)	and	additionally	described	as	extent	(localized	or	
generalized).	Grade	of	periodontitis	is	estimated	with	direct	or	indirect	evidence	of	
progression	 rate	 in	 three	categories:	 slow,	moderate	and	rapid	progression	 (Grade	
A‐C).	Risk	factor	analysis	is	used	as	grade	modifier.
Conclusions:	The	paper	describes	a	simple	matrix	based	on	stage	and	grade	to	ap‐
propriately	define	periodontitis	in	an	individual	patient.	The	proposed	case	definition	
extends	beyond	description	based	on	severity	to	include	characterization	of	biologi‐
cal	features	of	the	disease	and	represents	a	first	step	towards	adoption	of	precision	
medicine	concepts	to	the	management	of	periodontitis.	It	also	provides	the	neces‐
sary	framework	for	introduction	of	biomarkers	in	diagnosis	and	prognosis.
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INTRODUC TION: THE 1999 
CL A SSIFIC ATION OF PERIODONTITIS
Periodontitis	 is	 characterized	 by	 microbially‐associated,	 host‐me‐
diated	 inflammation	that	results	 in	 loss	of	periodontal	attachment.	
The	pathophysiology	of	the	disease	has	been	characterized	in	its	key	
molecular	pathways,	and	ultimately	 leads	 to	activation	of	host‐de‐
rived	proteinases	that	enable	loss	of	marginal	periodontal	ligament	
fibers,	apical	migration	of	the	junctional	epithelium,	and	allows	api‐
cal	spread	of	the	bacterial	biofilm	along	the	root	surface.	The	bac‐
terial	 biofilm	 formation	 initiates	 gingival	 inflammation;	 however,	
periodontitis	initiation	and	progression	depend	on	dysbiotic	ecolog‐
ical	changes	in	the	microbiome	in	response	to	nutrients	from	gingi‐
val	 inflammatory	and	tissue	breakdown	products	that	enrich	some	
species	and	anti‐bacterial	mechanisms	that	attempt	to	contain	the	
microbial	 challenge	within	 the	gingival	 sulcus	area	once	 inflamma‐
tion	has	initiated.	Current	evidence	supports	multifactorial	disease	
influences,	 such	 as	 smoking,	 on	multiple	 immunoinflammatory	 re‐
sponses	that	make	the	dysbiotic	microbiome	changes	more	likely	for	
some	patients	than	others	and	likely	influence	severity	of	disease	for	
such	individuals.
Marginal	alveolar	bone	 loss	–	a	key	secondary	 feature	of	peri‐
odontitis	–	is	coupled	with	loss	of	attachment	by	inflammatory	medi‐
ators.	Clinical	presentation	differs	based	on	age	of	patient	and	lesion	
number,	distribution,	severity,	and	 location	within	 the	dental	arch.	
The	 level	of	oral	biofilm	contamination	of	 the	dentition	also	 influ‐
ences	the	clinical	presentation.
In	 recent	decades,	attempts	 to	classify	periodontitis	have	cen‐
tered	on	a	dilemma	represented	by	whether	phenotypically	different	
case	presentations	represent	different	diseases	or	just	variations	of	
a	single	disease.	Lack	of	ability	to	resolve	the	issue	is	 illustrated	in	
the	changes	to	the	classification	system	that	progressively	empha‐
sized	either	differences	or	commonalities.1,2	Shortly	before	the	1999	
International	Workshop	 on	Classification	 of	 Periodontal	Diseases,	
research	in	the	field	emphasized	individual	features	of	periodontitis	
and	thus	differences	 in	phenotype.	These	emerged	from	the	 iden‐
tification	 of	 specific	 bacteria	 or	 bacterial	 complexes	 as	 etiologic	
agents	of	periodontitis,3	the	recognition	of	the	existence	of	multiple	
modifiable	 risk	 factors,4	 and	 the	 identification	of	 the	 relevance	of	
genetic	susceptibility5,6	and	specific	polymorphisms	associated	with	
disease	severity.7	The	research	perspective	on	the	disease	impacted	
the	 1999	 classification	 system	 that	 emphasized	 perceived	 unique	
features	of	different	periodontitis	phenotypes	and	led	to	the	recog‐
nition	of	four	different	forms	of	periodontitis:
1. Necrotizing	 periodontitis
2. Chronic	periodontitis
3. Aggressive	periodontitis
4. Periodontitis	as	a	manifestation	of	systemic	diseases
The	overall	classification	system	aimed	to	differentiate	the	more	
common	forms	of	periodontitis,	i.e.	chronic	and	aggressive	periodonti‐
tis,	from	the	unusual	necrotizing	form	of	the	disease	(characterized	by	
a	unique	pathophysiology,	distinct	clinical	presentation	and	treatment),	
and	the	rare	major	genetic	defects	or	acquired	deficiencies	in	compo‐
nents	of	host	defense	 (characterized	by	a	primary	systemic	disorder	
that	also	expresses	itself	by	premature	tooth	exfoliation).
The	 1999	 group	 consensus	 report	 on	 aggressive	 periodontitis	
identified	 specific	 features	 of	 this	 form	 of	 disease	 and	 proposed	
the	existence	of	major	and	minor	criteria	for	case	definition	as	well	
as	 distribution	 features	 to	 differentiate	 localized	 from	generalized	
forms	of	periodontitis.8	By	default,	cases	of	periodontitis	that	would	
not	satisfy	the	“aggressive”	phenotype	definition	would	be	classified	
as	“chronic”	with	the	implication	that	latter	cases	could	be	managed	
more	 easily	 and,	 with	 appropriate	 therapy	 and	maintenance	 care,	
would	 rarely	 jeopardize	 the	 retention	 of	 a	 functional	 dentition.9 
The	 rationale	 for	 differentiating	 between	 chronic	 and	 aggressive	
periodontitis	included	the	ability	to	identify	and	focus	on	the	more	
problematic	 cases:	 presenting	 with	 greater	 severity	 earlier	 in	 life,	
at	 higher	 risk	 of	 progression	 and/or	 in	 need	 of	 specific	 treatment	
approaches.
The	1999	workshop	addressed	a	host	of	concerns	with	the	clin‐
ical	applicability	and	pathophysiologic	rationale	of	previous	classifi‐
cation	systems	(see	Armitage	199910	for	discussion),	emphasized	the	
need	to	capture	differences	between	forms	of	 the	disease	able	 to	
lead	to	edentulism,	but	did	not	clearly	communicate	differences	be‐
tween	chronic	and	aggressive	periodontitis.	While	the	consensus	re‐
port	of	the	aggressive	periodontitis	working	group	articulated	major	
and	minor	criteria	required	for	the	aggressive	periodontitis	diagnosis	
as	well	as	specific	definitions	to	identify	patterns	of	distribution	of	
lesions	within	the	dentition	(localized	molar	incisor	versus	general‐
ized,	see	Lang	et	al.	19998	for	detailed	discussion),	the	difficulty	in	
applying	the	stipulated	criteria	in	the	everyday	clinical	practice	and	
the	substantial	overlap	between	the	diagnostic	categories	provided	
a	barrier	to	clinicians	in	the	application	of	the	classification	system.	
Furthermore,	the	validity	of	many	of	the	criteria	for	aggressive	peri‐
odontitis	has	not	been	confirmed	in	adequately	designed	studies.
Over	 the	past	2	decades	clinicians,	educators,	 researchers	and	
epidemiologists	have	voiced	concern	about	their	ability	to	correctly	
periodontitis,	grade	C	periodontitis,	inflammatory	burden,	infrabony	defect,	masticatory	
dysfunction,	necrotizing	periodontitis,	periodontal	pocket,	periodontitis,	periodontitis	as	
manifestation	of	systemic	disease,	periodontitis/grade,	periodontitis/stage,	radiographic	bone	
loss,	risk	factors,	stage	I	periodontitis,	stage	II	periodontitis,	stage	III	periodontitis,	stage	IV	
periodontitis,	standard	of	care,	tooth	hypermobility,	tooth	loss
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differentiate	 between	 aggressive	 and	 chronic	 periodontitis	 cases,	
and	these	difficulties	have	been	a	major	rationale	for	a	new	classifi‐
cation	workshop.11
SUMMARY AND INTERPRETATION OF 
E VIDENCE FROM CURRENT WORKSHOP 
POSITION PAPERS
To	 update	 evidence	 that	 has	 accumulated	 since	 the	 latest	 clas‐
sification	 workshop,	 the	 organizing	 committee	 commissioned	 a	
review	on	acute	periodontal	lesions	including	necrotizing	periodon‐
titis,12	 a	 review	of	manifestations	of	 systemic	diseases	 that	 affect	
the	 periodontal	 attachment	 apparatus,13	 and	 three	 position	 pa‐
pers	 that	 are	 relevant	 to	 the	discussion	of	 aggressive	 and	 chronic	
periodontitis.14‒16
The	position	papers	that	addressed	aggressive	and	chronic	peri‐
odontitis	reached	the	following	overarching	conclusions	relative	to	
periodontitis:
1. There	 is	 no	 evidence	 of	 specific	 pathophysiology	 that	 enables	
differentiation	 of	 cases	 that	 would	 currently	 be	 classified	 as	
aggressive	 and	 chronic	 periodontitis	 or	 provides	 guidance	 for	
different	 interventions.
2. There	 is	 little	 consistent	 evidence	 that	 aggressive	 and	 chronic	
periodontitis	are	different	diseases,	but	there	is	evidence	of	mul‐
tiple	 factors,	 and	 interactions	among	 them,	 that	 influence	clini‐
cally	observable	disease	outcomes	(phenotypes)	at	the	individual	
level.	 This	 seems	 to	 be	 true	 for	 both	 aggressive	 and	 chronic	
phenotypes.
3. On	a	population	basis,	the	mean	rates	of	periodontitis	progression	
are	 consistent	 across	 all	 observed	 populations	 throughout	 the	
world.
4. There	is	evidence,	however,	that	specific	segments	of	the	popula‐
tion	exhibit	different	levels	of	disease	progression,	as	indicated	by	
greater	 severity	 of	 clinical	 attachment	 loss	 (CAL)	 in	 subsets	 of	
each	age	cohort	relative	to	the	majority	of	individuals	in	the	age	
cohort.
5. A	classification	system	based	only	on	disease	severity	fails	to	cap‐
ture	important	dimensions	of	an	individual's	disease,	including	the	
complexity	that	 influences	approach	to	therapy,	the	risk	factors	
that	influence	likely	outcomes,	and	level	of	knowledge	and	train‐
ing	required	for	managing	the	individual	case.
Authors’ interpretation of current evidence reviews
There is sufficient evidence to consider necrotizing periodonti-
tis as a separate disease entity.	Evidence	comes	from:	 i)	a	distinct	
pathophysiology	characterized	by	prominent	bacterial	invasion	and	
ulceration	of	 epithelium;	 ii)	 rapid	 and	 full	 thickness	destruction	of	
the	marginal	soft	tissue	resulting	in	characteristic	soft	and	hard	tis‐
sue	defects;	iii)	prominent	symptoms;	and	iv)	rapid	resolution	in	re‐
sponse	to	specific	antimicrobial	treatment.
There is sufficient evidence to consider that periodontitis ob-
served in the context of systemic diseases that severely impair 
host response should be considered a periodontal manifestation 
of the systemic disease and that the primary diagnosis should 
be the systemic disease according to International Statistical 
Classification of Disease (ICD).13,17	 Many	 of	 these	 diseases	 are	
characterized	 by	 major	 functional	 impairment	 of	 host	 defenses	
and	have	multiple	non‐oral	sequelae.	At	the	moment	there	is	insuf‐
ficient	evidence	to	consider	that	periodontitis	observed	in	poorly	
controlled	 diabetes	 is	 characterized	 by	 unique	 pathophysiology	
and/or	requires	specific	periodontal	treatment	other	than	the	con‐
trol	of	both	co‐morbidities.18
Despite substantial research on aggressive periodontitis since 
the 1999 workshop,14 there is currently insufficient evidence to 
consider aggressive and chronic periodontitis as two pathophysio-
logically distinct diseases.
Current multifactorial models of disease applied to periodontitis 
appear to account for a substantial part of the phenotypic variation 
observed across cases as defined by clinical parameters.	Multiple	
observational	 studies	 in	 populations	 with	 long‐term	 exposure	 to	
microbial	 biofilms	 on	 the	 teeth	 have	 shown	 that	 a	 small	 segment	
of	 the	adult	population	expresses	 severe	generalized	periodontitis	
and	most	express	mild	to	moderate	periodontitis.19,20	It	is	also	well	
documented	using	twin	studies	that	a	large	portion	of	the	variance	
in	clinical	severity	of	periodontitis	is	attributable	to	genetics.5,6,21,22
It	 is	 reasonable	 to	 expect	 that	 future	 research	 advances	 will	
increase	 our	 knowledge	 of	 disease‐specific	 mechanisms	 in	 the	
context	of	the	multifactorial	biological	interactions	involved	in	spe‐
cific	 phenotypes.	 That	 pursuit	 may	 be	 valuable	 in	 guiding	 better	
management	of	 complex	 cases	 and	may	 lead	 to	novel	 approaches	
that	 enhance	 periodontitis	 prevention,	 control,	 and	 regeneration.	
Multi‐dimensional	 profiles	 that	 combine	 biological	 and	 clinical	 pa‐
rameters	are	emerging	that	better	define	phenotypes	and	may	guide	
deeper	understanding	of	the	mechanisms	that	lead	to	differences	in	
phenotypes.23‒26
There	is	clinical	value	in	individualizing	the	diagnosis	and	the	case	
definition	of	a	periodontitis	patient	to	take	into	account	the	known	
dimension	 of	 the	multifactorial	 etiology	 to	 improve	 prognosis,	 ac‐
count	 for	complexity	and	 risk,	and	provide	an	appropriate	 level	of	
care	for	the	individual.
INTEGR ATING CURRENT KNOWLEDGE 
TO ADVANCE CL A SSIFIC ATION OF 
PERIODONTITIS
Clinical definition of periodontitis
Periodontitis	is	characterized	by	microbially‐associated,	host‐me‐
diated	inflammation	that	results	in	loss	of	periodontal	attachment.	
This	 is	 detected	 as	 clinical	 attachment	 loss	 (CAL)	 by	 circumfer‐
ential	 assessment	 of	 the	 erupted	 dentition	 with	 a	 standardized	
periodontal	probe	with	reference	to	the	cemento‐enamel	junction	
(CEJ).
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It	is	important	to	note:
1. Some	 clinical	 conditions	 other	 than	 periodontitis	 present	 with	
clinical	 attachment	 loss.
2. Periodontitis	 definitions	 based	 on	 marginal	 radiographic	 bone	
loss	suffer	from	severe	limitations	as	they	are	not	specific	enough	
and	 miss	 detection	 of	 mild	 to	 moderate	 periodontitis.27 
Periodontitis	definitions	based	on	radiographic	bone	loss	should	
be	 limited	 to	 the	 stages	of	mixed	dentition	and	 tooth	eruption	
when	clinical	 attachment	 level	measurement	with	 reference	 to	
the	 CEJ	 are	 impractical.28	 In	 such	 cases	 periodontitis	 assess‐
ments	based	on	marginal	radiographic	bone	loss	may	use	bitew‐
ing	radiographs	taken	for	caries	detection.
Objectives of a periodontitis case definition system
A	case	definition	 system	 should	 facilitate	 the	 identification,	 treat‐
ment	 and	 prevention	 of	 periodontitis	 in	 individual	 patients.	Given	
current	 knowledge,	 a	 periodontitis	 case	 definition	 system	 should	
include	three	components:	
1. Identification	 of	 a	 patient	 as	 a	 periodontitis	 case,
2. Identification	of	the	specific	form	of	periodontitis,	and
3. Description	of	the	clinical	presentation	and	other	elements	that	
affect	clinical	management,	prognosis,	and	potentially	broader	in‐
fluences	on	both	oral	and	systemic	health.
Furthermore,	 case	 definitions	 may	 be	 applied	 in	 different	
contexts:	 patient	 care,	 epidemiological	 surveys	 and	 research	 on	
disease	 mechanisms	 or	 therapeutic	 outcomes,	 as	 discussed	 in	
Appendix	A	 in	the	online	Journal of Clinical Periodontology.	 In	the	
various	contexts,	case	definitions	may	require	different	diagnostic	
characteristics	based	on	the	objectives	of	the	specific	application,	
as	is	discussed	below.
Definition of a patient as a periodontitis case
Given	 the	 measurement	 error	 of	 clinical	 attachment	 level	 with	 a	
standard	periodontal	probe,	a	degree	of	misclassification	of	the	ini‐
tial	stage	of	periodontitis	is	inevitable	and	this	affects	diagnostic	ac‐
curacy.	As	disease	severity	increases,	CAL	is	more	firmly	established,	
and	 a	 periodontitis	 case	 can	 be	 identified	 with	 greater	 accuracy.	
Decreasing	the	threshold	of	CAL	increases	sensitivity.	Increasing	the	
threshold,	 requiring	CAL	at	 	≥1	 site,	 and	excluding	causes	of	CAL,	
other	than	periodontitis,	increases	specificity.
We	 should	 anticipate	 that	 until	more	 robust	methods	 are	 vali‐
dated,	 potentially	 salivary	 biomarkers	 or	 novel	 soft‐tissue	 imaging	
technologies,	the	level	of	training	and	experience	with	periodontal	
probing	will	 greatly	 influence	 the	 identification	of	 a	 case	of	 initial	
periodontitis.
It	 should	 be	 noted	 that	 periodontal	 inflammation,	 generally	
measured	 as	 bleeding	 on	 probing	 (BOP),	 is	 an	 important	 clinical	
parameter	 relative	 to	 assessment	 of	 periodontitis	 treatment	 out‐
comes	and	residual	disease	risk	post‐treatment.29‒32	However	BOP	
itself,	or	as	a	secondary	parameter	with	CAL,	does	not	change	the	
initial	case	definition	as	defined	by	CAL	or	change	the	classification	
of	periodontitis	severity.
Multiple	 periodontitis	 case	 definitions	 have	 been	 proposed	 in	
recent	years.	The	AAP/Centers	for	Disease	Control	(CDC)	case	defi‐
nition	for	epidemiologic	surveillance	and	the	EFP	case	definition	for	
the	purpose	of	risk	factors	research	have	been	widely	utilized.33,34 
Although	the	AAP/CDC	and	the	sensitive	EFP	definition	share	simi‐
larities	there	are	some	important	differences.
In	the	context	of	the	2017	World	Workshop,	it	is	suggested	that	
a	single	definition	be	adopted.
A	patient	is	a	periodontitis	case	in	the	context	of	clinical	care	if:
1. Interdental	 CAL	 is	 detectable	 at	≥2	 non‐adjacent	 teeth,	 or
2. Buccal	 or	 oral	 CAL	 ≥3	mm	with	 pocketing	>3	mm	 is	 detectable	
at	≥2	teeth
and	 the	 observed	 CAL	 cannot	 be	 ascribed	 to	 non‐periodontal	
causes	such	as:	1)	gingival	recession	of	traumatic	origin;	2)	dental	car‐
ies	extending	in	the	cervical	area	of	the	tooth;	3)	the	presence	of	CAL	
on	the	distal	aspect	of	a	second	molar	and	associated	with	malposition	
or	extraction	of	a	third	molar,	4)	an	endodontic	lesion	draining	through	
the	marginal	 periodontium;	 and	5)	 the	occurrence	of	 a	 vertical	 root	
fracture.
Key	to	periodontitis	case	definition	is	the	notion	of	“detectable”	
interdental	CAL:	the	clinician	being	able	to	specifically	identify	areas	
of	attachment	loss	during	periodontal	probing	or	direct	visual	detec‐
tion	of	the	interdental	CEJ	during	examination,	taking	measurement	
error	and	local	factors	into	account.
It	 is	 recognized	 that	 “detectable”	 interdental	 attachment	 loss	
may	represent	different	magnitudes	of	CAL	based	upon	the	skills	of	
the	operator	(e.g.	specialist	or	general	practitioner)	and	local	condi‐
tions	that	may	facilitate	or	impair	detection	of	the	CEJ,	most	notably	
the	position	of	the	gingival	margin	with	respect	to	the	CEJ,	the	pres‐
ence	of	calculus	or	restorative	margins.	The	proposed	case	definition	
does	not	stipulate	a	specific	 threshold	of	detectable	CAL	to	avoid	
misclassification	of	initial	periodontitis	cases	as	gingivitis	and	main‐
tain	consistency	of	histological	and	clinical	definitions.	There	is	also	a	
need	to	increase	specificity	of	the	definition	and	this	is	accomplished	
requiring	 detection	 of	 CAL	 at	 two	 non‐adjacent	 teeth.	 Setting	 a	
specific	threshold	of	CAL	for	periodontitis	definition	(e.g.	2	mm)	to	
address	measurement	error	with	CAL	detection	with	a	periodontal	
probe	would	result	 in	misclassification	of	 initial	periodontitis	cases	
as	gingivitis.	Specific	considerations	are	needed	for	epidemiological	
surveys	where	threshold	definition	is	likely	to	be	based	on	numerical	
values	dependent	on	measurement	errors.
Identification of the form of periodontitis
Based	 on	 pathophysiology,	 three	 clearly	 different	 forms	 of	 peri‐
odontitis	have	been	identified:
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1. Necrotizing	 periodontitis
2. Periodontitis	as	a	direct	manifestation	of	systemic	diseases
3. Periodontitis
Differential	diagnosis	is	based	on	history	and	the	specific	signs	and	
symptoms	of	 necrotizing	periodontitis	 and	 the	presence	or	 absence	
of	an	uncommon	systemic	disease	that	definitively	alters	the	host	im‐
mune	response.	Necrotizing	periodontitis	 is	characterized	by	history	
of	pain,	presence	of	ulceration	of	the	gingival	margin	and/or	fibrin	de‐
posits	at	sites	with	characteristically	decapitated	gingival	papillae,	and,	
in	some	cases,	exposure	of	the	marginal	alveolar	bone.	With	regard	to	
periodontitis	as	a	direct	manifestation	of	systemic	disease,	the	recom‐
mendation	is	to	follow	the	classification	of	the	primary	disease	accord‐
ing	to	the	respective	International	Statistical	Classification	of	Diseases	
and	Related	Health	Problems	(ICD)	codes.
The	vast	majority	of	clinical	cases	of	periodontitis	do	not	have	
the	local	characteristics	of	necrotizing	periodontitis	or	the	systemic	
characteristics	 of	 a	 rare	 immune	 disorder	with	 a	 secondary	mani‐
festation	 of	 periodontitis.	 The	 majority	 of	 clinical	 cases	 of	 peri‐
odontitis	present	with	a	range	of	phenotypes	that	require	different	
approaches	to	clinical	management	and	offer	different	complexities	
that	define	the	knowledge	and	experience	necessary	to	successfully	
manage	various	cases.
Additional elements proposed for inclusion in the 
classification of periodontitis
Since	 the	 1999	 International	 Classification	 Workshop,	 it	 has	 be‐
come	apparent	that	additional	information	beyond	the	specific	form	
of	periodontitis	 and	 the	 severity	 and	extent	of	periodontal	 break‐
down	 is	 necessary	 to	more	 specifically	 characterize	 the	 impact	 of	
past	disease	on	an	 individual	patient's	dentition	and	on	 treatment	
approaches	needed	to	manage	the	case.	Clinical	diagnosis	needs	to	
be	more	all‐encompassing	in	expressing	the	effects	of	periodontitis	
and	should	account	not	only	for	the	oral	effects	but	also	for	potential	
systemic	implications	of	the	disease.
Severity
The	 degree	 of	 periodontal	 breakdown	 present	 at	 diagnosis	 has	
long	been	used	as	the	key	descriptor	of	the	individual	case	of	peri‐
odontitis.	The	1999	case	definition	system	 is	also	based	on	sever‐
ity.	 Rationale	 of	 classification	 according	 to	 severity	 encompasses	
at	least	two	important	dimensions:	complexity	of	management	and	
extent	of	disease.	 Important	 limitations	of	 severity	definitions	 are	
worth	discussing	also	in	the	context	of	recent	therapeutic	improve‐
ments	 that	 have	 enabled	 successful	management	 of	 progressively	
more	severe	periodontitis.35	Conventional	definitions	of	severe	peri‐
odontitis	need	to	be	revised	to	better	discriminate	the	more	severe	
forms	of	periodontitis.	Another	important	limitation	of	current	defi‐
nitions	of	severe	periodontitis	is	a	paradox:	whenever	the	worst	af‐
fected	teeth	in	the	dentition	are	lost,	severity	may	actually	decrease.	
Tooth	loss	attributable	to	periodontitis	needs	to	be	incorporated	in	
the	definition	of	severity.
Complexity of management
Factors	such	as	probing	depths,36	type	of	bone	loss	(vertical	and/or	
horizontal),37	 furcation	 status,38	 tooth	mobility,39‒41	missing	 teeth,	
bite	 collapse,42	 and	 residual	 ridge	 defect	 size	 increase	 treatment	
complexity	and	need	to	be	considered	and	should	ultimately	 influ‐
ence	diagnostic	classification.	Explicit	designation	of	case	complex‐
ity	factors	helps	to	define	levels	of	competence	and	experience	that	
a	case	is	likely	to	require	for	optimal	outcomes.
Extent
The	number	and	the	distribution	of	teeth	with	detectable	periodon‐
tal	breakdown	has	been	part	of	current	classification	systems.	The	
number	of	affected	teeth	(as	a	percentage	of	teeth	present)	has	been	
used	to	define	cases	of	chronic	periodontitis	in	the	1999	classifica‐
tion9,10	while	the	distribution	of	lesions	(molar	incisor	versus	gener‐
alized	pattern	of	breakdown)	has	been	used	as	a	primary	descriptor	
for	aggressive	periodontitis.8,28	Rationale	for	keeping	this	 informa‐
tion	 in	 the	 classification	 system	comes	 from	 the	 fact	 that	 specific	
patterns	of	periodontitis	 (e.g.	 the	molar‐incisor	pattern	of	younger	
subjects	presenting	with	what	was	formerly	called	localized	juvenile	
periodontitis)	provide	 indirect	 information	about	the	specific	host‐
biofilm	interaction.
Rate of progression
One	of	the	most	important	aspects	for	a	classification	system	is	to	
properly	 account	 for	 variability	 in	 the	 rate	 of	 progression	 of	 peri‐
odontitis.	The	importance	of	this	criteria	has	been	well	recognized	
in	the	1989	AAP	classification	that	 identified	a	rapidly	progressing	
form	of	periodontitis.43	Concern	about	this	criterion	has	been	mostly	
on	how	to	assess	the	rate	of	progression	at	initial	examination	in	the	
absence	 of	 direct	 evidence	 (e.g.	 an	 older	 diagnostic	 quality	 radio‐
graph	allowing	comparison	of	marginal	bone	loss	over	time).
Risk factors
Recognized	risk	factors	have	not	been	previously	included	formally	
in	the	classification	system	of	periodontitis	but	have	been	used	as	
a	descriptor	to	qualify	the	specific	patient	as	a	smoker	or	a	patient	
with	diabetes	mellitus.	Improved	knowledge	of	how	risk	factors	af‐
fect	periodontitis	(higher	severity	and	extent	at	an	earlier	age)	and	
treatment	response	(smaller	degrees	of	improvements	in	surrogate	
outcomes	and	higher	rates	of	tooth	loss	during	supportive	periodon‐
tal	therapy40,41,44)	indicate	that	risk	factors	should	be	considered	in	
the	classification	of	periodontitis.
Interrelationship with general health
Since	the	1999	workshop	considerable	evidence	has	emerged	con‐
cerning	 potential	 effects	 of	 periodontitis	 on	 systemic	 diseases.	
Various	mechanisms	 linking	periodontitis	 to	multiple	 systemic	dis‐
eases	 have	 been	 proposed.45,46	 Specific	 oral	 bacteria	 in	 the	 peri‐
odontal	 pocket	 may	 gain	 bloodstream	 access	 through	 ulcerated	
pocket	epithelium.	 Inflammatory	mediators	from	the	periodontium	
may	enter	the	bloodstream	and	activate	liver	acute	phase	proteins,	
such	 as	 C‐reactive	 protein	 (CRP),	 which	 further	 amplify	 systemic	
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inflammation	 levels.	 Case‐control47‒50	 and	 pilot	 intervention	 stud‐
ies51,52	show	that	periodontitis	contributes	to	the	overall	inflamma‐
tory	burden	of	the	individual	which	is	strongly	implicated	in	coronary	
artery	disease,	stroke,	and	Type	II	diabetes.53‒58	Initial	evidence	also	
supports	the	potential	role	of	the	overall	systemic	inflammatory	bur‐
den	on	the	risk	for	periodontitis.59
Modestly	sized	periodontitis	 treatment	studies	of	uncontrolled	
Type	 II	 diabetes	 have	 shown	 value	 in	 reducing	 hyperglycemia,	 al‐
though	 reductions	 in	 hyperglycemia	 have	 not	 been	 supported	 in	
some	 larger	 studies	 where	 the	 periodontal	 treatment	 outcomes	
were	 less	 clear.18,60,61	 Although	 intriguing	 health	 economics	 anal‐
yses	 have	 shown	 a	 reduction	 in	 cost	 of	 care	 for	multiple	medical	
conditions	following	treatment	for	periodontitis,62	little	direct	peri‐
odontitis	 intervention	 evidence,	 beyond	 the	 diabetes	 experience,	
has	 convincingly	 demonstrated	 the	 potential	 value	 of	 effectively	
treating	periodontitis	relative	to	overall	health	benefits.	Current evi-
dence that effective treatment of certain cases of periodontitis can 
favorably influence systemic diseases or their surrogates, although 
limited, is intriguing and should definitively be assessed.
Other	factors	that	need	to	be	considered	in	formulating	a	diag‐
nostic	classification	include	the	medical	status	of	the	patient	and	the	
level	of	expertise	needed	to	provide	appropriate	care.	If	the	patient	
has	severe	systemic	disease,	as	indicated	by	their	American	Society	
of	Anesthesiologists	 (ASA)	status,	 this	can	seriously	affect	 the	cli‐
nician's	 ability	 to	 control	 disease	 progression	 due	 to	 the	 patient's	
inability	 to	withstand	proper	 treatment	or	 their	 inability	 to	attend	
necessary	maintenance	care.
FR AME WORK FOR DE VELOPING A 
PERIODONTITIS STAGING AND GR ADING 
SYSTEM
New	technologies	and	therapeutic	approaches	to	periodontitis	man‐
agement	are	now	available	such	that	clinicians	with	advanced	train‐
ing	can	manage	patients	with	moderate	and	severe	periodontitis	to	
achieve	clinical	outcomes	that	were	not	previously	possible.
The	 other	 dimension	 not	 previously	 available	 in	 our	 classifica‐
tion	is	the	directed	identification	of	individual	patients	who	are	more	
likely	 to	 require	 greater	 effort	 to	 prevent	 or	 control	 their	 chronic	
disease	 long‐term.	 This	 explicitly	 acknowledges	 the	 evidence	 that	
most	 individuals	and	patients	 respond	predictably	 to	conventional	
approaches	 to	 prevent	 periodontitis	 and	 conventional	 therapeutic	
approaches	and	maintenance,	while	others	may	require	more	inten‐
sive	and	more	frequent	preventive	care	or	therapeutic	interventions,	
monitoring,	and	maintenance.19,20,63‒65
Staging,	an	approach	used	for	many	years	 in	oncology,	has	been	
recently	discussed	relative	to	periodontal	disease66	and	affords	an	op‐
portunity	to	move	beyond	the	one‐dimensional	approach	of	using	past	
destruction	alone	and	furnishes	a	platform	on	which	a	multidimensional	
diagnostic	classification	can	be	built.	Furthermore,	a	uniform	staging	
system	should	provide	a	way	of	defining	the	state	of	periodontitis	at	
various	points	in	time,	can	be	readily	communicated	to	others	to	assist	
in	treatment,	and	may	be	a	factor	in	assessing	prognosis.	Periodontitis	
staging	should	assist	clinicians	 in	considering	all	 relevant	dimensions	
that	help	optimize	individual	patient	management	and	thus	represents	
a	critical	step	towards	personalized	care	(or	precision	medicine).
Staging	relies	on	the	standard	dimensions	of	severity	and	extent	
of	 periodontitis	 at	 presentation	 but	 introduces	 the	 dimension	 of	
complexity	of	managing	the	individual	patient.
As	 it	 is	 recognized	 that	 individuals	 presenting	with	 different	 se‐
verity/extent	 and	 resulting	 complexity	 of	management	may	 present	
different	rates	of	progression	of	the	disease	and/or	risk	factors,	the	in‐
formation	derived	from	the	staging	of	periodontitis	should	be	supple‐
mented	by	information	on	the	inherent	biological	grade	of	the	disease.	
This	relies	on	three	sets	of	parameters:	1)	rate	of	periodontitis	progres‐
sion;	2)	recognized	risk	factors	for	periodontitis	progression;	and	3)	risk	
of	an	individual's	case	affecting	the	systemic	health	of	the	subject.
The	 concept	 and	value	 of	 “staging”	 has	 been	 extensively	 devel‐
oped	in	the	oncology	field.	Staging	of	tumors	is	based	on	current	ob‐
servable	clinical	presentation	including	size	or	extent	and	whether	it	
has	metastasized.	This	may	be	an	example	of	how	one	might	commu‐
nicate	current	severity	and	extent	of	a	disease,	as	well	as	the	clinical	
complexities	of	managing	the	case.	To	supplement	staging,	which	pro‐
vides	a	summary	of	clinical	presentation,	grade	has	been	used	as	an	as‐
sessment	of	the	potential	for	a	specific	tumor	to	progress,	i.e.	to	grow	
and	spread,	based	on	microscopic	appearance	of	tumor	cells.	In	addi‐
tion,	current	molecular	markers	often	guide	selection	of	specific	drug	
therapies,	and	thereby	incorporate	biological	targets	that	increase	the	
granularity	 of	 the	 grade	 and	 thus	may	 increase	 the	 probability	 of	 a	
favorable	clinical	outcome.	These	concepts	have	been	adapted	to	peri‐
odontitis,	as	summarized	in	Table	1,	and	as	described	in	detail	below.
While	 devising	 a	 general	 framework,	 it	 seems	 relevant	 from	 a	
patient	management	standpoint	to	differentiate	four	stages	of	peri‐
odontitis.	Each	of	these	stages	is	defined	by	unique	disease	presen‐
tation	in	terms	of	disease	severity	and	complexity	of	management.	
In	each	stage	of	severity,	it	may	be	useful	to	identify	subjects	with	
TA B L E  1  Primary	goals	in	staging	and	grading	a	patient	with	
periodontitis
Staging a Periodontitis Patient
• Goals
◦ Classify Severity and Extent	of	an	individual	based	on	
currently	measurable	extent	of	destroyed	and	damaged	
tissue	attributable	to	periodontitis
◦ Assess Complexity.	Assess	specific	factors	that	may	
determine	complexity	of	controlling	current	disease	and	
managing	long‐term	function	and	esthetics	of	the	patient's	
dentition
Grading a Periodontitis Patient
• Goals
◦ Estimate Future Risk	of	periodontitis	progression	and	
responsiveness	to	standard	therapeutic	principles,	to	guide	
intensity	of	therapy	and	monitoring
◦ Estimate Potential Health Impact of Periodontitis on 
systemic	disease	and	the	reverse,	to	guide	systemic	
monitoring	and	co‐therapy	with	medical	colleagues
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different	rates	of	disease	progression	and	it	is	foreseen	that,	in	the	
future,	stage	definition	will	be	enriched	by	diagnostic	tests	enabling	
definition	of	the	biological	“grade”	and/or	susceptibility	of	periodon‐
titis	progression	in	the	individual	patient.	The	addition	of	grade	may	
be	 achieved	 by	 refining	 each	 individual's	 stage	 definition	 with	 a	
grade	A,	B,	or	C,	in	which	increasing	grades	will	refer	to	those	with	
direct	or	 indirect	evidence	of	different	 rates	of	periodontal	break‐
down	and	presence	and	level	of	control	of	risk	factors.
An	individual	case	may	thus	be	defined	by	a	simple	matrix	of	stage	
at	presentation	(severity	and	complexity	of	management)	and	grade	
(evidence	or	risk	of	progression	and	potential	risk	of	systemic	impact	
of	the	patient's	periodontitis;	these	also	influence	the	complexity	of	
management	of	 the	case).	Table	2	 illustrates	 this	concept	and	pro‐
vides	a	general	framework	that	will	allow	updates	and	revisions	over	
time	as	specific	evidence	becomes	available	to	better	define	individ‐
ual	components,	particularly	in	the	biological	grade	dimension	of	the	
disease	and	the	systemic	implications	of	periodontitis.
Stage I periodontitis
Stage	I	periodontitis	is	the	borderland	between	gingivitis	and	peri‐
odontitis	and	 represents	 the	early	 stages	of	attachment	 loss.	As	
such,	patients	with	stage	I	periodontitis	have	developed	periodon‐
titis	 in	 response	to	persistence	of	gingival	 inflammation	and	bio‐
film	dysbiosis.	They	represent	more	 than	 just	an	early	diagnosis:	
if	 they	 show	 a	 degree	 of	 clinical	 attachment	 loss	 at	 a	 relatively	
early	 age,	 these	 patients	 may	 have	 heightened	 susceptibility	 to	
disease	 onset.	 Early	 diagnosis	 and	 definition	 of	 a	 population	 of	
susceptible	individuals	offers	opportunities	for	early	intervention	
and	monitoring	that	may	prove	more	cost‐effective	at	the	popula‐
tion	level	as	shallow	lesions	may	provide	specific	options	for	both	
conventional	 mechanical	 biofilm	 removal	 and	 pharmacological	
agents	 delivered	 in	 oral	 hygiene	 aids.	 It	 is	 recognized	 that	 early	
diagnosis	may	 be	 a	 formidable	 challenge	 in	 general	 dental	 prac‐
tice:	periodontal	probing	to	estimate	early	clinical	attachment	loss	
–	 the	 current	 gold	 standard	 for	 defining	 periodontitis	 –	may	 be	
inaccurate.	Assessment	of	salivary	biomarkers	and/or	new	imaging	
technologies	may	increase	early	detection	of	stage	I	periodontitis	
in	a	variety	of	settings.
Stage II periodontitis
Stage	II	represents	established	periodontitis	in	which	a	carefully	per‐
formed	clinical	periodontal	examination	identifies	the	characteristic	
damages	that	periodontitis	has	caused	to	tooth	support.	At	this	stage	
of	 the	 disease	 process,	 however,	 management	 remains	 relatively	
simple	for	many	cases	as	application	of	standard	treatment	princi‐
ples	 involving	 regular	 personal	 and	 professional	 bacterial	 removal	
and	monitoring	 is	 expected	 to	 arrest	 disease	 progression.	 Careful	
evaluation	of	the	stage	II	patient's	response	to	standard	treatment	
principles	 is	essential,	and	the	case	grade	plus	treatment	response	
may	guide	more	intensive	management	for	specific	patients.
Stage III periodontitis
At	 stage	 III,	 periodontitis	 has	 produced	 significant	 damage	 to	 the	
attachment	apparatus	and,	 in	 the	absence	of	advanced	 treatment,	
tooth	loss	may	occur.	The	stage	is	characterized	by	the	presence	of	
deep	periodontal	 lesions	 that	extend	 to	 the	middle	portion	of	 the	
root	and	whose	management	is	complicated	by	the	presence	of	deep	
intrabony	 defects,	 furcation	 involvement,	 history	 of	 periodontal	
tooth	 loss/exfoliation,	and	presence	of	 localized	ridge	defects	that	
complicate	implant	tooth	replacement.	In	spite	of	the	possibility	of	
tooth	loss,	masticatory	function	is	preserved,	and	treatment	of	peri‐
odontitis	does	not	require	complex	rehabilitation	of	function.
Stage IV periodontitis
At	 the	more	 advanced	 stage	 IV,	 periodontitis	 causes	 considerable	
damage	to	the	periodontal	support	and	may	cause	significant	tooth	
loss,	and	 this	 translates	 to	 loss	of	masticatory	 function.	 In	 the	ab‐
sence	of	proper	control	of	the	periodontitis	and	adequate	rehabilita‐
tion,	the	dentition	is	at	risk	of	being	lost.
This	stage	is	characterized	by	the	presence	of	deep	periodontal	
lesions	that	extend	to	the	apical	portion	of	the	root	and/or	history	of	
multiple	tooth	loss;	it	is	frequently	complicated	by	tooth	hypermobil‐
ity	due	to	secondary	occlusal	trauma	and	the	sequelae	of	tooth	loss:	
posterior	 bite	 collapse	 and	 drifting.	 Frequently,	 case	management	
requires	stabilization/restoration	of	masticatory	function.
TA B L E  2  Framework	for	staging	and	grading	of	periodontitis
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Grade of periodontitis
Irrespective	 of	 the	 stage	 at	 diagnosis,	 periodontitis	 may	 progress	
with	different	rates	 in	 individuals,	may	respond	less	predictably	to	
treatment	 in	some	patients,	and	may	or	may	not	 influence	general	
health	or	systemic	disease.	This	information	is	critical	for	precision	
medicine	 but	 has	 been	 an	 elusive	 objective	 to	 achieve	 in	 clinical	
practice.	 In	 recent	 years,	 validated	 risk	 assessment	 tools25,67 and 
presence	of	 individually	 validated	 risk	 factors65	 have	been	 associ‐
ated	with	tooth	loss,	indicating	that	it	is	possible	to	estimate	risk	of	
periodontitis	progression	and	tooth	loss.
In	 the	past,	grade	of	periodontitis	progression	has	been	 incorpo‐
rated	into	the	classification	system	by	defining	specific	forms	of	peri‐
odontitis	with	 high(er)	 rates	 of	 progression	 or	 presenting	with	more	
severe	 destruction	 relatively	 early	 in	 life.28	 One	 major	 limitation	 in	
the	 implementation	of	 this	knowledge	has	been	the	assumption	that	
such	forms	of	periodontitis	represent	different	entities	and	thus	focus	
has	been	placed	on	identification	of	the	form	rather	than	the	factors	
contributing	to	progression.	The	reviews	commissioned	for	this	work‐
shop13–16	 have	 indicated	 that	 there	 is	 no	 evidence	 to	 suggest	 that	
such	forms	of	periodontitis	have	a	unique	pathophysiology,	rather	the	
complex	interplay	of	risk	factors	in	a	multifactorial	disease	model	may	
explain	 the	 phenotypes	 of	 periodontitis	 in	 exposed	 patients.	 In	 this	
context,	it	seems	useful	to	provide	a	framework	for	implementation	of	
biological	grade	(risk	or	actual	evidence	of	progression)	of	periodontitis.
Recognized	risk	factors,	such	as	cigarette	smoking	or	metabolic	
control	of	diabetes,	 affect	 the	 rate	of	progression	of	periodontitis	
and,	consequently,	may	increase	the	conversion	from	one	stage	to	
the	next.	Emerging	risk	factors	like	obesity,	specific	genetic	factors,	
physical	activity,	or	nutrition	may	one	day	contribute	to	assessment,	
and	a	flexible	approach	needs	to	be	devised	to	ensure	that	the	case‐
definition	system	will	adapt	to	the	emerging	evidence.
Disease	severity	at	presentation/diagnosis	as	a	 function	of	pa‐
tient	age	has	also	been	an	important	indirect	assessment	of	the	level	
of	individual	susceptibility.	While	not	ideal	–	as	it	requires	significant	
disease	 at	 an	 early	 age	or	minimal	 disease	 at	 advanced	 age	–	 this	
concept	has	been	used	in	clinical	practice	and	risk	assessment	tools	
to	identify	highly	susceptible	or	relatively	resistant	individuals.	One	
approach	has	been	 the	 assessment	of	 bone	 loss	 in	 relation	 to	pa‐
tient	age	by	measuring	radiographic	bone	loss	in	percentage	of	root	
length	divided	by	the	age	of	the	patient.	This	approach	was	originally	
applied	in	a	longitudinal	assessment	of	disease	progression	assessed	
in	intraoral	radiographs68,69	and	was	later	incorporated	in	the	theo‐
retical	concept	that	 led	to	development	of	the	periodontal	risk	as‐
sessment	 (PRA)	system.31,70	More	recently,	an	 individual's	severity	
of	CAL	has	been	compared	to	his/her	age	cohort.16	This	information	
from	large	and	diverse	populations	could	be	considered	an	age	stan‐
dard	for	CAL,	with	the	assumption	that	individuals	who	exceed	the	
mean	CAL	threshold	for	a	high	percentile	 in	the	age	cohort	would	
be	one	additional	piece	of	objective	information	that	may	represent	
increased	risk	for	future	progression.	The	CAL	must	be	adjusted	in	
some	way	based	on	 number	 of	missing	 teeth	 to	 avoid	 biasing	 the	
CAL	based	on	measuring	 only	 remaining	 teeth	 after	 extraction	 of	
the	teeth	with	the	most	severe	periodontitis.	Such	challenges	again	
require	a	framework	that	will	adapt	to	change	as	more	precise	ways	
to	estimate	individual	susceptibility	become	available.
Integrating biomarkers in a case definition system
Clinical	 parameters	 are	 very	 effective	 tools	 for	 monitoring	 the	
health‐disease	states	in	most	patients,	likely	because	they	respond	
favorably	 to	 the	 key	 principles	 of	 periodontal	 care,	which	 include	
regular	disruption,	and	reduction	of	the	gingival	and	subgingival	mi‐
crobiota.	Current	evidence	suggests,	however,	that	some	individuals	
are	more	susceptible	to	develop	periodontitis,	more	susceptible	to	
develop	 progressive	 severe	 generalized	 periodontitis,	 less	 respon‐
sive	to	standard	bacterial	control	principles	for	preventing	and	treat‐
ing	periodontitis,	and	theoretically	more	likely	to	have	periodontitis	
adversely	impact	systemic	diseases.
If,	due	to	multiple	factors,	such	individuals	are	more	likely	than	
others	 to	 develop	 and	maintain	 a	 dysbiotic	 microbiota	 in	 concert	
with	chronic	periodontal	inflammation;	it	is	unclear	whether	current	
clinical	 parameters	 are	 sufficient	 to	monitor	 disease	 development	
and	treatment	responses	in	such	patients.	For	those	individuals,	bio‐
markers,	some	of	which	are	currently	available,	may	be	valuable	to	
augment	information	provided	by	standard	clinical	parameters.
Biomarkers	may	contribute	 to	 improved	diagnostic	accuracy	 in	
the	early	detection	of	periodontitis	and	are	likely	to	provide	decisive	
contributions	to	a	better	assessment	of	the	grade	of	periodontitis.	
They	may	 assist	 both	 in	 staging	 and	 grading	 of	 periodontitis.	 The	
proposed	framework	allows	introduction	of	validated	biomarkers	in	
the	case	definition	system.
Integrating knowledge of the interrelationship 
between periodontal health and general health in a 
case definition system
At	present	there	is	only	emerging	evidence	to	identify	specific	peri‐
odontitis	 cases	 in	 which	 periodontal	 treatment	 produces	 general	
health	 benefits.	 it	 is	 important	 to	 identify	 approaches	 to	 capture	
some	dimensions	of	the	potential	systemic	impact	of	a	specific	peri‐
odontitis	case	and	its	treatment	to	provide	the	basis	for	focusing	at‐
tention	on	this	issue	and	beginning	to	collect	evidence	necessary	to	
assess	whether	effective	treatment	of	certain	cases	of	periodontitis	
truly	influence	systemic	disease	in	a	meaningful	way.
Specific	 considerations	 for	 use	 of	 the	 staging	 and	 grading	 of	
periodontitis	with	epidemiological	and	research	applications	are	dis‐
cussed	in	Appendix	B	in	the	online	Journal of Clinical Periodontology.
INCORPOR ATION OF STAGING AND 
GR ADING IN THE C A SE DEFINITION 
SYSTEM OF PERIODONTITIS
A	 case	 definition	 system	needs	 to	 be	 a	 dynamic	 process	 that	will	
require	revisions	over	time	in	much	the	same	way	the	tumor,	node,	
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metastasis	 (TNM)	staging	system	for	cancer	has	been	shaped	over	
many	decades.	It	needs	to	be:
1. Simple	 enough	 to	 be	 clinically	 applicable	 but	 not	 simplistic:	
additional	knowledge	has	distinguished	dimensions	of	periodon‐
titis,	 such	 as	 complexity	 of	 managing	 the	 case	 to	 provide	 the	
best	 level	 of	 care
2. Standardized	 to	 be	 able	 to	 support	 effective	 communication	
among	all	stakeholders
3. Accessible	to	a	wide	range	of	people	in	training	and	understood	
by	members	of	the	oral	health	care	team	around	the	world
It	is	suggested	that	a	case	definition	based	on	a	matrix	of	periodon‐
titis	stage	and	periodontitis	grade	be	adopted.	Such	multidimensional	
view	of	periodontitis	would	create	the	potential	to	transform	our	view	
of	periodontitis.	And	the	powerful	outcome	of	that	multidimensional	
view	is	the	ability	to	communicate	better	with	patients,	other	profes‐
sionals,	and	third	parties.
Stage of periodontitis (Table 3)
At	present,	relevant	data	are	available	to	assess	the	two	dimensions	
of	 the	 staging	 process:	 severity	 and	 complexity.	 These	 can	be	 as‐
sessed	in	each	individual	case	at	diagnosis	by	appropriate	anamnes‐
tic,	clinical,	and	imaging	data.
The	severity	score	is	primarily	based	on	interdental	CAL	in	rec‐
ognition	of	low	specificity	of	both	pocketing	and	marginal	bone	loss,	
although	marginal	bone	loss	is	also	included	as	an	additional	descrip‐
tor.	 It	 follows	 the	general	 frame	of	previous	severity‐based	scores	
and	is	assigned	based	on	the	worst	affected	tooth	in	the	dentition.	
Only	 attachment	 loss	 attributable	 to	 periodontitis	 is	 used	 for	 the	
score.
The	 complexity	 score	 is	 based	 on	 the	 local	 treatment	 com‐
plexity	 assuming	 the	 wish/need	 to	 eliminate	 local	 factors	 and	
takes	 into	 account	 factors	 like	 presence	 of	 vertical	 defects,	 fur‐
cation	 involvement,	 tooth	 hypermobility,	 drifting	 and/or	 flar‐
ing	of	 teeth,	 tooth	 loss,	 ridge	deficiency	and	 loss	of	masticatory	
TA B L E  3  Periodontitis	stage	–	Please	see	text	and	appendix	A	(in	online	Journal of Clinical Periodontology)	for	explanation
The	initial	stage	should	be	determined	using	CAL;	if	not	available	then	RBL	should	be	used.	Information	on	tooth	loss	that	can	be	attributed	primarily	
to	periodontitis	–	if	available	–	may	modify	stage	definition.	This	is	the	case	even	in	the	absence	of	complexity	factors.	Complexity	factors	may	shift	
the	stage	to	a	higher	level,	for	example	furcation	II	or	III	would	shift	to	either	stage	III	or	IV	irrespective	of	CAL.	The	distinction	between	stage	III	and	
stage	IV	is	primarily	based	on	complexity	factors.	For	example,	a	high	level	of	tooth	mobility	and/or	posterior	bite	collapse	would	indicate	a	stage	IV	
diagnosis.	For	any	given	case	only	some,	not	all,	complexity	factors	may	be	present,	however,	in	general	it	only	takes	one	complexity	factor	to	shift	the	
diagnosis	to	a	higher	stage.	It	should	be	emphasized	that	these	case	definitions	are	guidelines	that	should	be	applied	using	sound	clinical	judgment	to	
arrive	at	the	most	appropriate	clinical	diagnosis.
For	post‐treatment	patients	CAL	and	RBL	are	still	the	primary	stage	determinants.	If	a	stage‐shifting	complexity	factor(s)	is	eliminated	by	treatment,	
the	 stage	 should	 not	 retrogress	 to	 a	 lower	 stage	 since	 the	 original	 stage	 complexity	 factor	 should	 always	 be	 considered	 in	 maintenance	 phase	
management.
CAL	=	clinical	attachment	loss;	RBL	=	radiographic	bone	loss.
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function.	Besides	 the	 local	complexity,	 it	 is	 recognized	 that	 indi‐
vidual	 case	management	may	be	complicated	by	medical	 factors	
or	comorbidities.
The	diagnostic	classification	presented	in	Table	3	provides	defi‐
nitions	 for	 four	stages	of	periodontitis.	 In	using	 the	 table,	 it	 is	 im‐
portant	to	use	CAL	as	the	 initial	stage	determinant	 in	the	severity	
dimension.	It	is	recognized	that	in	clinical	practice	application	some	
clinicians	may	prefer	to	use	diagnostic	quality	radiographic	imaging	
as	an	indirect	and	somehow	less	sensitive	assessment	of	periodontal	
breakdown.	This	may	be	all	that	is	necessary	to	establish	the	stage.	
However,	 if	other	factors	are	present	 in	the	complexity	dimension	
that	influence	the	disease	then	modification	of	the	initial	stage	as‐
signment	may	be	required.	For	example,	in	case	of	very	short	com‐
mon	root	trunk	a	CAL	of	4	mm	may	have	resulted	in	class	II	furcation	
involvement,	hence	shifting	the	diagnosis	from	stage	 II	 to	stage	 III	
periodontitis.	Likewise,	if	posterior	bite	collapse	is	present	then	the	
stage	 IV	would	be	 the	appropriate	 stage	diagnosis	 since	 the	 com‐
plexity	is	on	the	stage	IV	level.
Evidence	for	defining	different	stages	based	on	CAL/bone	loss	in	
relation	to	root	length	is	somewhat	arbitrary.
Patients	who	have	been	treated	for	periodontitis	may	be	pe‐
riodically	staged	to	monitor	them.	In	most	of	successfully	treated	
patients,	complexity	factors	that	might	have	contributed	to	base‐
line	 staging	will	 have	 been	 resolved	 through	 treatment.	 In	 such	
patients	 CAL	 and	 radiographic	 bone	 loss	 (RBL)	 will	 be	 the	 pri‐
mary	stage	determinants.	 If	a	stage	shifting	complexity	 factor(s)	
were	eliminated	by	treatment,	the	stage	should	not	retrogress	to	
a	 lower	 stage	 since	 the	 original	 stage	 complexity	 factor	 should	
always	be	considered	 in	maintenance	phase	management.	A	no‐
table	exception	 is	 successful	periodontal	 regeneration	 that	may,	
through	improvement	of	tooth	support,	effectively	improve	CAL	
and	RBL	of	the	specific	tooth.
Grade of periodontitis (Table 4)
Grading	adds	another	dimension	and	allows	rate	of	progression	to	
be	 considered.	Table	4	 illustrates	periodontitis	 grading	based	on	
primary	criteria	represented	by	the	availability	of	direct	or	indirect	
evidence	of	periodontitis	progression.	Direct	evidence	is	based	on	
longitudinal	observation	available	for	example	in	the	form	of	older	
diagnostic	quality	radiographs.	 Indirect	evidence	 is	based	on	the	
assessment	of	bone	 loss	at	 the	worst	affected	 tooth	 in	 the	den‐
tition	 as	 a	 function	 of	 age	 (measured	 as	 radiographic	 bone	 loss	
in	 percentage	 of	 root	 length	 divided	 by	 the	 age	 of	 the	 subject).	
Periodontitis	grade	can	then	be	modified	by	the	presence	of	risk	
factors.
The	objective	of	grading	is	to	use	whatever	information	is	avail‐
able	to	determine	the	likelihood	of	the	case	progressing	at	a	greater	
rate	than	is	typical	for	the	majority	of	the	population	or	responding	
less	predictably	to	standard	therapy.
Clinicians	 should	 approach	 grading	 by	 assuming	 a	 moderate	
rate	of	progression	(grade	B)	and	look	for	direct	and	indirect	mea‐
sures	of	actual	progression	in	the	past	as	a	means	of	improving	the	
establishment	of	prognosis	for	the	individual	patient.	If	the	patient	
has	 risk	 factors	 that	have	been	associated	with	more	disease	pro‐
gression	or	less	responsiveness	to	bacterial	reduction	therapies,	the	
risk	factor	information	can	be	used	to	modify	the	estimate	of	the	pa‐
tient's	future	course	of	disease.	A	risk	factor,	should	therefore	shift	
the	grade	score	to	a	higher	value	independently	of	the	primary	cri‐
terion	represented	by	the	rate	of	progression.	For	example,	a	stage	
and	 grade	 case	 definition	 could	 be	 characterized	 by	moderate	 at‐
tachment	loss	(stage	II),	the	assumption	of	moderate	rate	of	progres‐
sion	(grade	B)	modified	by	the	presence	of	poorly	controlled	Type	II	
diabetes	(a	risk	factor	that	is	able	to	shift	the	grade	definition	to	rapid	
progression	or	grade	C).
In	 summary,	 a	 periodontitis	 diagnosis	 for	 an	 individual	 patient	
should	encompass	three	dimensions:
1. Definition	 of	 a	 periodontitis	 case	 based	 on	 detectable	 CAL	
loss	 at	 two	 non‐adjacent	 teeth
2. Identification	of	the	form	of	periodontitis:	necrotizing	periodonti‐
tis,	 periodontitis	 as	 a	 manifestation	 of	 systemic	 disease	 or	
periodontitis
3. Description	of	the	presentation	and	aggressiveness	of	the	disease	
by	stage	and	grade	 (see	Appendix	B	 in	online	Journal of Clinical 
Periodontology)
CONCLUSIONS
The	 proposed	 staging	 and	 grading	 of	 periodontitis	 provides	 an	
individual	 patient	 assessment	 that	 classifies	 patients	 by	 two	 di‐
mensions	beyond	severity	and	extent	of	disease	that	identify	pa‐
tients	as	to	complexity	of	managing	the	case	and	risk	of	the	case	
exhibiting	more	 progression	 and/or	 responding	 less	 predictably	
to	standard	periodontal	therapy.	The	proposed	risk	stratification	
is	based	on	well‐validated	risk	factors	including	smoking,	uncon‐
trolled	Type	II	diabetes,	clinical	evidence	of	progression	or	disease	
diagnosis	at	an	early	age,	and	severity	of	bone	loss	relative	to	pa‐
tient	age.
The	proposed	 staging	 and	grading	explicitly	 acknowledges	 the	
potential	 for	 some	 cases	 of	 periodontitis	 to	 influence	 systemic	
disease.	The	current	proposal	does	not	 intend	to	minimize	the	 im‐
portance	or	 extent	 of	 evidence	 supporting	direct	 distal	 effects	 of	
periodontal	 bacteremia	 on	 adverse	 pregnancy	 outcomes	 and	 po‐
tentially	other	systemic	conditions;	but	focuses	on	the	role	of	peri‐
odontitis	as	the	second	most	frequent	factor	(obesity	being	the	most	
frequent)	 that	 is	 well‐documented	 as	 a	 modifiable	 contributor	 to	
systemic	inflammatory	burden.
The	 proposed	 staging	 and	 grading	 is	 designed	 to	 avoid	 the	
paradox	 of	 improvement	 of	 disease	 severity	 observed	 after	 loss/
extraction	of	the	more	compromised	teeth.	This	is	achieved	by	incor‐
porating,	whenever	available,	knowledge	about	periodontitis	being	
the	predominant	reason	for	loss	of	one	or	more	teeth.
Finally,	one	of	the	strong	benefits	of	the	staging	and	grading	of	
periodontitis	 is	 that	 it	 is	designed	 to	accommodate	 regular	 review	
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by	an	ad	hoc	international	task	force	to	ensure	that	the	framework	
incorporates	relevant	new	knowledge	within	an	already	functioning	
clinical	application.
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